<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01562977</url>
  </required_header>
  <id_info>
    <org_study_id>GEL-TAMO/R-GemOx-08-04/v2</org_study_id>
    <nct_id>NCT01562977</nct_id>
  </id_info>
  <brief_title>Study to Evaluate Efficacy and Tolerance of R-GemOx in DLBCL and MCL</brief_title>
  <acronym>RGemOx</acronym>
  <official_title>Prospective, Open-label, Multicentric, ph. II Study of R-GemOx and Dexametasone in Patients With Agressive Lymphomas Refractory or Relapsed to Previous Treatment and Non Eligible for High-dose Chemotherapy Followed by Autologous Stem Cell Transplanted</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine efficacy of rituximab, gemcitabine, oxaliplatin and
      dexametasone (R-GemOx) chemotherapy schedule.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to determine efficacy (overall response rate (ORR) and complete
      response) tolerance and toxicity of rituximab, gemcitabine, oxaliplatin and dexametasone
      (R-GemOx) chemotherapy schedule.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2011</start_date>
  <completion_date type="Actual">April 2015</completion_date>
  <primary_completion_date type="Actual">April 2015</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The primary endpoint is to evaluate Overall response rate (ORR)</measure>
    <time_frame>3 years and 2 months</time_frame>
    <description>The primary endpoint is to evaluate the number of patients with complete remission, unconfirmed complete remission and partial response according to International Workshop to Standardize Response Criteria for NHL, of R-GEMOX combination administered every 14 days</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Safety of Gemcitabine in combination with Rituximab, Oxaliplatin and Dexametasone (R-GemOx) in DLBCL and Mantle cell lymphoma. (GELTAMO-RGemOx)</measure>
    <time_frame>3 years and 2 months</time_frame>
    <description>To asses the number of Participants with Adverse Events (serious and non serious) and classification of those adverse events.
Evaluate if the balance efficacy / toxicity allows the possibility of further interventions to prolong progression-free survival and overall survival</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To identify clinical response predictive factors</measure>
    <time_frame>3 years 2 months</time_frame>
    <description>To asses if different age, sex, IPI, ECOG, stage of cancer, dissease location and time to relapse have some influence in response.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">82</enrollment>
  <condition>Aggressive Lymphoma</condition>
  <condition>Diffuse Large B-cell Lymphoma</condition>
  <condition>Mantle Cell Lymphoma</condition>
  <arm_group>
    <arm_group_label>no arms</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>no arms were present for the study, only 2 different cohorts:MCL and LDCGB</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Rituximab, Gemcitabine, Oxaliplatin, Dexametasone</intervention_name>
    <description>until progression or unacceptable toxicity develops, 8 cicles max Rituximab: 375 mg/m2, IV, day 1. Gemcitabine: 1000 mg/m2, IV, day 2. Oxaliplatin: 100 mg/m2, IV, day 2. Dexametasone: 20 mg/day, days 1-3, oral.</description>
    <arm_group_label>no arms</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age ≥ 18 years.

          2. DLBCL and MCL diagnosed patients in primary resistance or relapsed not eligible for
             intensification chemotherapy followed by Autologous stem cell transplantation (ASCT)
             for age, comorbidity or previous ASCT.

          3. Any IPI or ECOG, capable of understanding the nature of the trial.

          4. Writtern Informed Consent.

        Exclusion Criteria:

          1. Nursing pregnant or lactation period women, or fertile age adults not using effective
             contraceptive method.

          2. CNS lymphoma patients.

          3. Patients with severa renal (creatinine&gt; 2,5 UNL) or hepatic (Bilirrubin or ALT/AST&gt;
             2,5 UNL) impairement not provided by the same disease

          4. HIV positive patients.

          5. Serious psychiatric diseases patients that could interfere with their skill to
             understand the study (including alcoholism or drug addiction).

          6. Murine proteins or any other component of the medicines of the study hypersensitivity
             patients.

          7. Patients who have received more than 2 therapeutic previous lines. (for previous ASCT
             patients, induction and conditioning for the TAPH treatment is considered a single
             line therapy).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andrés López Hernández, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Vall d´Hebrón</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mª Dolores Caballero Barrigón, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Clínico de Salamanca</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jorge Gayoso Cruz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Universitario Gregorio Marañón</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Juan Alfonso Soler Campos, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Corporació Sanitari Parc Taulí</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Carlos Montalbán Sanz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Universitario Ramon y Cajal</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Juan Manuel Sancho Cía, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Germans Trias i Pujol Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Isidro Jarque, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital La Fe de Valencia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Secundino Ferrer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Dr. Peset</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Carlos Grande, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital 12 de Octubre</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Pilar Martínez Barranco, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fundación Hospital de Alcorcón</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Miguel Ángel Canales Albendea, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital La Paz</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jose Antonio García Marco, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Puerta de Hierro de Majadahonda</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Roberto Hernández Martín, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Virgen de la Concha</affiliation>
  </overall_official>
  <overall_official>
    <last_name>José Manuel Calvo Villas, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Dr. Jose Molina Orosa</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Miguel Hernández, García</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Universitario de Canarias</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Elena Pérez Ceballos, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Morales Meseguer</affiliation>
  </overall_official>
  <overall_official>
    <last_name>José M. Moraleda Jiménez, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Virgen de la Arrixaca</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Eulogio Conde García, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Marqués de Valdecilla</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Carlos Panizo Santos, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clínica Universitaria Navarra</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mª Rosario Varela, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Complejo Hospitalario A Coruña</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jose Luis Bello López, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Complejo Hospitalario Universitario de Santiago</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Maria José Ramírez Sánchez, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital del SAS Jerez</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Luis Palomera, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Clínico Lozano Blesa</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Pilar Giraldo, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Miguel Servet</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Antonio Gutiérrez, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Son Espasses</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Joan Bargay Leonart, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Son Llàtzer</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Eva González Barca, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Duran i Reynals</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Javier Briones Meijide, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Santa Creu i Sant Pau</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital Germans Trias i Pujol</name>
      <address>
        <city>Badalona</city>
        <state>Barcelona</state>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Duran i Reynals</name>
      <address>
        <city>Sabadell</city>
        <state>Barcelona</state>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital SAS de Jerez</name>
      <address>
        <city>Jerez de la Frontera</city>
        <state>Cádiz</state>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Dr. Jose Molina Orosa</name>
      <address>
        <city>Arrecife</city>
        <state>Lanzarote</state>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fundación Hospital de Alcorcón</name>
      <address>
        <city>Alcorcón</city>
        <state>Madrid</state>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Puerta de Hierro de Majadahonda</name>
      <address>
        <city>Majadahonda</city>
        <state>Madrid</state>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Virgen de Arrixaca</name>
      <address>
        <city>El Palmar</city>
        <state>Murcia</state>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Complejo Hospitalario de A Coruña</name>
      <address>
        <city>A Coruña</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Santa Creu i Sant Pau</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Vall d´Hebrón</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital 12 Octubre</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Gregorio Marañón</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital La Paz</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Ramón y Cajal</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Morales Meseguer</name>
      <address>
        <city>Murcia</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Son Espasses</name>
      <address>
        <city>Palma de Mallorca</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Son Llàtzer</name>
      <address>
        <city>Palma de Mallorca</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinica Universitaria de Navarra</name>
      <address>
        <city>Pamplona</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Corporació Sanitari Parc Taulí</name>
      <address>
        <city>Sabadell</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Clínico de Salamanca</name>
      <address>
        <city>Salamanca</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de Canarias</name>
      <address>
        <city>Santa Cruz de Tenerife</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Marqués de Valdecilla</name>
      <address>
        <city>Santander</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Complejo Hospitalario Universitario de Santiago</name>
      <address>
        <city>Santiago de Compostela</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Dr. Peset</name>
      <address>
        <city>Valencia</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital La Fe</name>
      <address>
        <city>Valencia</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Virgen de la Concha</name>
      <address>
        <city>Zamora</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Clínico Lozano Blesa</name>
      <address>
        <city>Zaragoza</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Miguel Servet</name>
      <address>
        <city>Zaragoza</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 18, 2011</study_first_submitted>
  <study_first_submitted_qc>March 22, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 26, 2012</study_first_posted>
  <last_update_submitted>October 27, 2017</last_update_submitted>
  <last_update_submitted_qc>October 27, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 30, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea</investigator_affiliation>
    <investigator_full_name>Ana Mendez Lopez</investigator_full_name>
    <investigator_title>Sponsor's secretary</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lymphoma</mesh_term>
    <mesh_term>Lymphoma, B-Cell</mesh_term>
    <mesh_term>Lymphoma, Mantle-Cell</mesh_term>
    <mesh_term>Lymphoma, Large B-Cell, Diffuse</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gemcitabine</mesh_term>
    <mesh_term>Oxaliplatin</mesh_term>
    <mesh_term>Rituximab</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

